Chunghwa Chemical Synthesis & Biotech Company Overview
- Year Founded
-
1964
- Status
-
Public
- Employees
-
243
- Stock Symbol
-
1762
- Investments
-
1
- Share Price
-
$0.82
- (As of Friday Closing)
Chunghwa Chemical Synthesis & Biotech Company General Information
Description
Chunghwa Chemical Synthesis & Biotech Co Ltd is engaged in the research, development, manufacturing, and sales of pharmaceutical products. Geographically, it derives a majority of its revenue from the United States and also has a presence in Taiwan. Its product portfolio comprises pain management, antifungal, immunosuppressant, oncology, Cardiovascular, Peptide Drugs, and Others.
Contact Information
Website
www.ccsb.com.twCorporate Office
- 1 Tung-Hsing Street
- New Taipei City, Shu-Lin District 238-50
- Taiwan
Corporate Office
- 1 Tung-Hsing Street
- New Taipei City, Shu-Lin District 238-50
- Taiwan
Chunghwa Chemical Synthesis & Biotech Company Stock Performance
As of 20-Nov-2026, Chunghwa Chemical Synthesis & Biotech Company’s stock price is $0.82. Its current market cap is $63.4M with 76.9M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.82 | $0.88 | $0.77 - $1.42 | $63.4M | 76.9M | 94.3K | -$0.02 |
Chunghwa Chemical Synthesis & Biotech Company Financials Summary
As of 30-Sep-2026, Chunghwa Chemical Synthesis & Biotech Company has a trailing 12-month revenue of $31.6M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 96,230 | 77,990 | 104,672 | 174,834 |
| Revenue | 31,595 | 25,801 | 41,987 | 66,985 |
| EBITDA | 5,969 | (1,647) | 8,517 | 17,294 |
| Net Income | (955) | (7,817) | 1,653 | 8,505 |
| Total Assets | 132,841 | 138,051 | 144,835 | 168,304 |
| Total Debt | 20,551 | 25,768 | 26,097 | 39,349 |
Chunghwa Chemical Synthesis & Biotech Company Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Chunghwa Chemical Synthesis & Biotech Company Patents
Chunghwa Chemical Synthesis & Biotech Company Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12552751-B2 | Crystal forms a, b, c, d, e, f and g of selumetinib sulfate and preparation methods thereof | Active | 01-Jun-2023 | ||
| US-20240400519-A1 | Crystal forms a, b, c, d, e, f and g of selumetinib sulfate and preparation methods thereof | Active | 01-Jun-2023 | ||
| US-12479882-B2 | Preparation method of setmelanotide by cyclization of disulfide bond in solid phase | Active | 15-Dec-2022 | ||
| US-20240199685-A1 | Preparation method of setmelanotide by cyclization of disulfide bond in solid phase | Active | 15-Dec-2022 | ||
| US-12006324-B1 | Preparation method of trilaciclib and precursors of trilaciclib | Active | 15-Dec-2022 | C07D487/14 |
Chunghwa Chemical Synthesis & Biotech Company Signals
Chunghwa Chemical Synthesis & Biotech Company Investments (1)
Chunghwa Chemical Synthesis & Biotech Company’s most recent deal was a Joint Venture with Joint Venture (Chunghwa Chemical Synthesis & Biotech Company / BioDuro-Sundia). The deal was made on 03-Mar-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Joint Venture (Chunghwa Chemical Synthesis & Biotech Company / BioDuro-Sundia) | 03-Mar-2026 | Joint Venture | Drug Discovery |
Chunghwa Chemical Synthesis & Biotech Company ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Chunghwa Chemical Synthesis & Biotech Company FAQs
-
When was Chunghwa Chemical Synthesis & Biotech Company founded?
Chunghwa Chemical Synthesis & Biotech Company was founded in 1964.
-
Where is Chunghwa Chemical Synthesis & Biotech Company headquartered?
Chunghwa Chemical Synthesis & Biotech Company is headquartered in New Taipei City, Taiwan.
-
What is the size of Chunghwa Chemical Synthesis & Biotech Company?
Chunghwa Chemical Synthesis & Biotech Company has 243 total employees.
-
What industry is Chunghwa Chemical Synthesis & Biotech Company in?
Chunghwa Chemical Synthesis & Biotech Company’s primary industry is Biotechnology.
-
Is Chunghwa Chemical Synthesis & Biotech Company a private or public company?
Chunghwa Chemical Synthesis & Biotech Company is a Public company.
-
What is Chunghwa Chemical Synthesis & Biotech Company’s stock symbol?
The ticker symbol for Chunghwa Chemical Synthesis & Biotech Company is 1762.
-
What is the current stock price of Chunghwa Chemical Synthesis & Biotech Company?
As of 20-Nov-2026 the stock price of Chunghwa Chemical Synthesis & Biotech Company is $0.82.
-
What is the current market cap of Chunghwa Chemical Synthesis & Biotech Company?
The current market capitalization of Chunghwa Chemical Synthesis & Biotech Company is $63.4M.
-
What is Chunghwa Chemical Synthesis & Biotech Company’s current revenue?
The trailing twelve month revenue for Chunghwa Chemical Synthesis & Biotech Company is $31.6M.
-
What is Chunghwa Chemical Synthesis & Biotech Company’s annual earnings per share (EPS)?
Chunghwa Chemical Synthesis & Biotech Company’s EPS for 12 months was -$0.02.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process